89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Positron-Emission Tomography
  • Prostatic Neoplasms
  • Radioisotopes
  • Zirconium

abstract

  • (89)Zr-huJ591 PET imaging of prostate-specific membrane antigen expression is safe and shows good localization of disease in prostate cancer patients. Liver is the critical organ for dosimetry, and 7 ± 1 days is the optimal imaging time. A larger study is underway to determine lesion detection in an expanded cohort of patients with metastatic prostate cancer.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4404641

Digital Object Identifier (DOI)

  • 10.1007/s00259-014-2830-7

PubMed ID

  • 25143071

Additional Document Info

start page

  • 2093

end page

  • 105

volume

  • 41

number

  • 11